Breaking News Instant updates and real-time market news.

NVRO

Nevro

$44.76

0.37 (0.83%)

06:31
03/20/19
03/20
06:31
03/20/19
06:31

New Nevro management a positive for shares, says JPMorgan

JPMorgan analyst Robbie Marcus views the stepping down of Nevro CEO Rami Elghandour as a positive for the shares. The announcement follows two challenging years for the company, with "several notable stops and false starts ultimately culminating in the stock falling from grace," Marcus tells investors in a research note. With the appointment of Keith Grossman as the company's new CEO and the addition of two "experienced, well-regarded" appointees to the board, the stock will likely receive a "notable bump," says the analyst. However, the suspension of revenue guidance likely means that estimates will not being moving up in the near-term, with a potential move downward as new management resets the bar going forward, adds the analyst. Marcus remains on the sidelines with a Neutral rating on Nevro.

  • 20

    Mar

  • 21

    Mar

NVRO Nevro
$44.76

0.37 (0.83%)

11/27/18
UBSW
11/27/18
INITIATION
UBSW
Sell
Nevro initiated with a Sell at UBS
UBS analyst Matthew Taylor initiated Nevro with a Sell rating and $35 price target, calling the stock a Top Sell. Taylor noted that Nevro's HF10 therapy has "changed the face of neuromod," but added that it has also "spurred competition from large, entrenched players."
02/22/19
BMOC
02/22/19
DOWNGRADE
Target $46
BMOC
Market Perform
Nevro downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Joanne Wuensch downgraded Nevro to Market Perform and kept her $46 price target after its Q4 earnings miss and a lower than expected outlook for FY19. The analyst points to the expected declines in revenues outside the U.S., driven by reimbursement changes in Australia, as well as the company's "minimal explanation" for this forecast, which she attributes to potential seasonality, sales rep hire dynamics, or the management's conservative outlook.
03/19/19
BMOC
03/19/19
UPGRADE
BMOC
Outperform
Nevro upgraded to Outperform from Market Perform at BMO Capital
03/19/19
BMOC
03/19/19
UPGRADE
Target $67
BMOC
Outperform
Nevro upgraded to Outperform at BMO Capital on new CEO appointment
BMO Capital analyst Joanne Wuensch upgraded Nevro to Outperform and raised her price target to $67 from $46. The analyst states that she has long believed that the stock offers value, but the company's "successive downward revisions and management missteps" took her to the sidelines. With the appointment of Keith Grossman - a 20 year veteran in the medical device industry - as new CEO, along with two new board members, the analyst contends that Nevro is positioned for a turnaround, even if it required the company to suspend guidance.

TODAY'S FREE FLY STORIES

ZTO

ZTO Express

$22.44

0.09 (0.40%)

15:04
11/18/19
11/18
15:04
11/18/19
15:04
Options
ZTO Express options imply 8.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

AMZN

Amazon.com

$1,752.30

14.81 (0.85%)

, SPOT

Spotify

$142.13

-5.22 (-3.54%)

14:59
11/18/19
11/18
14:59
11/18/19
14:59
Hot Stocks
Amazon Music to offer free ad-supported option »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,752.30

14.81 (0.85%)

SPOT

Spotify

$142.13

-5.22 (-3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

LCNB

LCNB Corp.

$17.93

-0.26 (-1.43%)

14:59
11/18/19
11/18
14:59
11/18/19
14:59
Hot Stocks
LCNB Corp. raises dividend 5.88% to 18c per share »

LCNB Corp. declared a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
11/18/19
11/18
14:55
11/18/19
14:55
General news
Fed's Rosengren repeated the economy is in a good place »

Fed's Rosengren…

SPOT

Spotify

$142.01

-5.34 (-3.62%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Spotify debuts 'Soundtrack your Ride' feature to make playlists for road trips »

Over this past weekend,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

DIS

Disney

$148.24

3.61 (2.50%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Periodicals
Disney+ accounts of thousands of users hacked, Cheddar says »

Disney+ users have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$16.49

-0.22 (-1.32%)

14:49
11/18/19
11/18
14:49
11/18/19
14:49
Options
Bilibili options imply 13.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

BAP

Credicorp

$210.20

-0.45 (-0.21%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Hot Stocks
Credicorp reports testimony of chairman in Peruvian government investigation »

Credicorp announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$8.29

-0.03 (-0.36%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:41
11/18/19
11/18
14:41
11/18/19
14:41
Hot Stocks
GlobalSCAPE announces $3.35 per share special cash dividend, $5M buyback program »

GlobalSCAPE announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$162.37

5.115 (3.25%)

, NTDOY

Nintendo

$0.00

(0.00%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Periodicals
Roku rolls out fix after new 'Pokemon' games cause crashing problems, Verge says »

Roku (ROKU) confirmed…

ROKU

Roku

$162.37

5.115 (3.25%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FB

Facebook

$197.78

2.71 (1.39%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Hot Stocks
Facebook's Oculus Link launches beta to play PC Rift games wired to Quest »

Oculus said in-part in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.